SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Dec-23 4:16 PM View: | Biovie Inc. (BIVI) | 01-Dec-23 | Sale | 75,680 | $1.69 | $127,899.00 | (62%) 122.04K to 46.36K | |
06-Dec-23 4:16 PM View: | Biovie Inc. (BIVI) | 09-Nov-23 | Grant | 46,358 | -- | -- | 61% 75.68K to 122.04K | |
07-Sep-23 6:20 PM View: | Biovie Inc. (BIVI) | 05-Sep-23 | Sale | 8,560 | $3.05 | $26,108.00 | (10%) 84.24K to 75.68K | |
18-Jan-23 4:32 PM View: | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 34,240 | -- | -- | 68% 50.0K to 84.24K | |
15-Dec-20 3:01 PM View: | Biovie Inc. (BIVI) | 03-Nov-20 | Purchase | 2,430 | $7.95 | $19,318.50 | 6% 42.67K to 45.1K | |
15-Dec-20 3:00 PM View: | Biovie Inc. (BIVI) | 30-Oct-20 | Purchase | 2,570 | $7.97 | $20,482.90 | 6% 40.1K to 42.67K | |
22-Oct-20 3:10 PM View: | Biovie Inc. (BIVI) | 21-Oct-20 | Purchase | 5,000 | $9.19 | $45,950.00 | 14% 35.1K to 40.1K | |
19-Oct-20 2:59 PM View: | Biovie Inc. (BIVI) | 15-Oct-20 | Purchase | 10,000 | $10.06 | $100,550.00 | 28% 35.1K to 45.1K | |
19-Oct-20 2:59 PM View: | Biovie Inc. (BIVI) | 15-Oct-20 | Purchase | 5,100 | $10.19 | $51,967.00 | 11% 45.1K to 50.2K | |
14-Oct-20 2:07 PM View: | Biovie Inc. (BIVI) | 09-Oct-20 | Purchase | 282 | $9.61 | $2,710.02 | 1% 19.72K to 20.0K | |
14-Oct-20 2:05 PM View: | Biovie Inc. (BIVI) | 07-Oct-20 | Purchase | 4,718 | $9.42 | $44,443.60 | 31% 15.0K to 19.72K | |
14-Oct-20 1:49 PM View: | Biovie Inc. (BIVI) | 22-Sep-20 | Purchase | 15,000 | $10.00 | $150,000.00 | 100% 0 to 15.0K | |
23-Oct-20 10:00 PM View: | Biovie Inc. (BIVI) | 16-Jun-20 | Disposition (change in control) | -- | -- | -- | 0% -- | |
08-Aug-19 5:00 PM View: | Majesco Entertainment Co. (PTE) | 06-Aug-19 | Grant | 29,718 | -- | -- | 2286% 1.3K to 31.02K | |
12-Jun-19 5:00 PM View: | Majesco Entertainment Co. (PTE) | 10-Jun-19 | Market Sale | 53,700 | $5.94 | $318,978.00 | (98%) 55.0K to 1.3K | 89% |
07-Jun-19 4:43 PM View: | Immunitybio, Inc. (IBRX) | 06-Jun-19 | Grant | 92,592 | -- | -- | 100% 0 to 92.59K | |
29-Nov-18 7:36 PM View: | Immunitybio, Inc. (IBRX) | 29-Nov-18 | Market Sale | 34,019 | $1.70 | $57,784.70 | (20%) 172.37K to 138.35K | (1316%) |
03-Dec-18 5:44 PM View: | Immunitybio, Inc. (IBRX) | 29-Nov-18 | Market Sale | 138,349 | $1.65 | $228,276.00 | (100%) 138.35K to 0 | (1358%) |
29-Nov-18 7:36 PM View: | Immunitybio, Inc. (IBRX) | 28-Nov-18 | Market Sale | 17,140 | $1.76 | $30,125.30 | (9%) 189.51K to 172.37K | (1269%) |
29-Nov-18 7:36 PM View: | Immunitybio, Inc. (IBRX) | 27-Nov-18 | Market Sale | 100,000 | $1.75 | $175,200.00 | (35%) 289.51K to 189.51K | (1273%) |
26-Nov-18 7:21 PM View: | Immunitybio, Inc. (IBRX) | 23-Nov-18 | Market Sale | 9,312 | $2.01 | $18,717.10 | (3%) 298.82K to 289.51K | (1097%) |
26-Nov-18 7:21 PM View: | Immunitybio, Inc. (IBRX) | 21-Nov-18 | Market Sale | 22,900 | $2.02 | $46,216.80 | (7%) 321.72K to 298.82K | (1092%) |
14-Nov-18 8:07 PM View: | Immunitybio, Inc. (IBRX) | 14-Nov-18 | Market Sale | 115,930 | $2.21 | $255,718.00 | (26%) 437.65K to 321.72K | (991%) |
14-Nov-18 8:07 PM View: | Immunitybio, Inc. (IBRX) | 13-Nov-18 | Market Sale | 33,300 | $2.40 | $79,886.70 | (7%) 470.95K to 437.65K | (903%) |
14-Nov-18 8:07 PM View: | Immunitybio, Inc. (IBRX) | 12-Nov-18 | Market Sale | 47,050 | $2.43 | $114,463.00 | (9%) 518.0K to 470.95K | (889%) |
27-Aug-18 7:47 PM View: | Immunitybio, Inc. (IBRX) | 27-Aug-18 | Market Sale | 18,300 | $3.09 | $56,462.80 | (3%) 536.3K to 518.0K | (678%) |
27-Aug-18 7:47 PM View: | Immunitybio, Inc. (IBRX) | 24-Aug-18 | Market Sale | 10,225 | $3.07 | $31,340.60 | (2%) 546.52K to 536.3K | (683%) |
27-Aug-18 7:47 PM View: | Immunitybio, Inc. (IBRX) | 23-Aug-18 | Market Sale | 21,475 | $3.06 | $65,709.20 | (4%) 568.0K to 546.52K | (685%) |
18-Jun-18 9:55 PM View: | Hythiam Inc. (OTRK) | 15-Jun-18 | Market Purchase | 20,235 | $8.40 | $170,057.00 | 27% 75.0K to 95.23K | |
18-Jun-18 9:55 PM View: | Hythiam Inc. (OTRK) | 15-Jun-18 | Market Purchase | 4,765 | $8.60 | $40,965.60 | 5% 95.23K to 100.0K | |
07-Jun-18 8:21 PM View: | Immunitybio, Inc. (IBRX) | 07-Jun-18 | Market Sale | 26,957 | $3.66 | $98,614.10 | (5%) 594.96K to 568.0K | (556%) |
07-Jun-18 8:21 PM View: | Immunitybio, Inc. (IBRX) | 06-Jun-18 | Market Sale | 23,574 | $3.79 | $89,272.40 | (4%) 618.53K to 594.96K | (534%) |
07-Jun-18 8:21 PM View: | Immunitybio, Inc. (IBRX) | 05-Jun-18 | Market Sale | 28,925 | $3.75 | $108,339.00 | (4%) 647.46K to 618.53K | (541%) |
01-Jun-18 4:23 PM View: | Immunitybio, Inc. (IBRX) | 30-May-18 | Market Sale | 2,724 | $3.88 | $10,563.90 | (< 1%) 650.18K to 647.46K | (519%) |
29-May-18 7:53 PM View: | Immunitybio, Inc. (IBRX) | 29-May-18 | Market Sale | 2,100 | $3.89 | $8,174.50 | (< 1%) 652.28K to 650.18K | (517%) |
29-May-18 7:53 PM View: | Immunitybio, Inc. (IBRX) | 25-May-18 | Market Sale | 3,600 | $3.97 | $14,294.00 | (< 1%) 655.88K to 652.28K | (505%) |
29-May-18 7:53 PM View: | Immunitybio, Inc. (IBRX) | 24-May-18 | Market Sale | 303 | $3.96 | $1,199.88 | (< 1%) 656.18K to 655.88K | (506%) |
23-May-18 9:38 PM View: | Immunitybio, Inc. (IBRX) | 22-May-18 | Market Sale | 8,546 | $3.81 | $32,560.30 | (1%) 664.73K to 656.18K | (530%) |
23-May-18 9:38 PM View: | Immunitybio, Inc. (IBRX) | 21-May-18 | Market Sale | 5,557 | $3.90 | $21,672.30 | (< 1%) 670.29K to 664.73K | (516%) |
22-May-18 8:41 PM View: | Immunitybio, Inc. (IBRX) | 18-May-18 | Market Sale | 15,971 | $3.97 | $63,412.90 | (2%) 686.26K to 670.29K | (505%) |
17-May-18 6:53 PM View: | Immunitybio, Inc. (IBRX) | 17-May-18 | Market Sale | 38,708 | $4.00 | $154,929.00 | (5%) 724.97K to 686.26K | (500%) |
17-May-18 6:53 PM View: | Immunitybio, Inc. (IBRX) | 16-May-18 | Market Sale | 16,200 | $4.05 | $65,634.30 | (2%) 741.16K to 724.97K | (493%) |
17-May-18 6:53 PM View: | Immunitybio, Inc. (IBRX) | 15-May-18 | Market Sale | 26,835 | $4.13 | $110,890.00 | (3%) 768.0K to 741.16K | (481%) |
13-Nov-17 6:33 AM View: | Majesco Entertainment Co. (PTE) | 10-Nov-17 | Grant | 5,000 | -- | -- | 27% 18.33K to 23.33K | |
01-Nov-17 6:39 PM View: | Innoveren Scientific, Inc. (IVRN) | 30-Oct-17 | Grant | 10,684 | $1.17 | $12,500.30 | < 1% 1.63M to 1.64M | (9%) |
13-Sep-17 8:20 PM View: | Immunitybio, Inc. (IBRX) | 13-Sep-17 | Market Sale | 39,604 | $5.93 | $234,729.00 | (5%) 807.6K to 768.0K | (305%) |
12-Sep-17 6:12 PM View: | Immunitybio, Inc. (IBRX) | 12-Sep-17 | Market Sale | 35,811 | $6.03 | $215,833.00 | (4%) 843.41K to 807.6K | (298%) |
12-Sep-17 6:12 PM View: | Immunitybio, Inc. (IBRX) | 11-Sep-17 | Market Sale | 53,307 | $6.03 | $321,468.00 | (6%) 896.72K to 843.41K | (298%) |
12-Sep-17 6:12 PM View: | Immunitybio, Inc. (IBRX) | 08-Sep-17 | Market Sale | 14,723 | $6.12 | $90,116.50 | (2%) 911.45K to 896.72K | (292%) |
22-Aug-17 9:45 AM View: | Innoveren Scientific, Inc. (IVRN) | 21-Aug-17 | Market Purchase | 50,000 | $1.25 | $62,500.00 | 3% 1.58M to 1.63M | (57%) |